OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Oncology Hematology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Trastuzumab deruxtecan in breast cancer	150
Research update for ferroptosis and cholangiocarcinoma	111
Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis	109
Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis	98
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting	77
Treatment of melanoma brain metastases with radiation and immunotherapy or targeted therapy: A systematic review with meta-analysis	68
Genomic biology and therapeutic strategies of liver metastasis from gastric cancer	67
Unlocking the intricacies: Exploring the complex interplay between platelets and ovarian cancer	62
Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities	61
Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review	59
Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer	59
Management of acute spinal cord compression in multiple myeloma	55
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practice	54
Epigenetics in advanced renal cell carcinoma: Potential new targets	53
The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients	50
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients	50
Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials	49
Current status of locally advanced rectal cancer therapy and future prospects	47
Targeting androgen receptor in glioblastoma	45
Application of molecular imaging in immune checkpoints therapy: From response assessment to prognosis prediction	45
Diagnosis and treatment of therapy-related acute myeloid leukemia	43
Comprehensive approach to cancer immunotherapy – Simultaneous targeting of myeloid-derived suppressor cells and cancer cells with AFP conjugates	43
Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence	42
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II	42
Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape	42

International consensus on the initial diagnostic workup of cancer of unknown primary	41
Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: A systematic review	38
Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis	36
Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy	35
Dose and volume de-escalation of radiotherapy in head and neck cancer	35
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives	35
Recent strategies to overcome breast cancer resistance	35
Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action	34
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma	34
Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia	34
Comprehensive review of solid tumor bone marrow metastasis	34